Sinopep-Allsino Biopharmaceutical Co. Ltd. A (688076): Kapitalflussrechnung
| Preis (11.09.2026) | 52W Hoch | 52W Tief |
| 28,03 Renminbi Yuan | 44,136 Renminbi Yuan | 25,7 Renminbi Yuan |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 88 Renminbi Yuan | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 316.815.961 | - | - |
Kennzahl in 1000 CNY | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Umsatz | 1.942.799,144 | 1.624.801,884 | 1.033.548,078 | 651.291,706 | 643.869,464 | 566.872,462 | 371.530,569 | 255.527,35 | 228.867,458 | 8.509,227 | 8.777,246 |
Cashflow aus operativer Geschäftstätigkeit | 681.242,899 | 400.116,077 | 350.213,817 | 29.292,086 | 180.746,199 | 141.381,334 | 46.135,933 | 96.057,443 | 11.110,07 | -21.951,56 | -112.624,909 |
▸ Operative Cashflow Marge | 35,07% | 24,63% | 33,88% | 4,5% | 28,07% | 24,94% | 12,42% | 37,59% | 4,85% | -257,97% | -1.283,15% |
Investitionsausgaben (CapEx) | 1.367.010,214 | 1.090.121,833 | 660.639,131 | 438.362,527 | 233.355,949 | 111.283,537 | 276.387,801 | 197.484,032 | 73.339,173 | 11.138,778 | 12.070,93 |
Cashflow aus Investitionstätigkeit | - | -1.393.192,173 | -662.208,813 | -449.743,026 | -236.930,71 | -163.175,126 | -275.713,801 | -210.307,41 | -47.760,714 | -11.129,873 | -12.070,93 |
Cashflow aus Finanzierungstätigkeit | - | 799.754,597 | 631.895,981 | 236.912,874 | 534.890,959 | 39.502,401 | 98.591,261 | 284.484,513 | 54.575,982 | 875,57 | 154.625,643 |
Freier Cashflow | -685.767,316 | -690.005,756 | -310.425,314 | -409.070,441 | -52.609,749 | 30.097,797 | -230.251,868 | -101.426,589 | -62.229,103 | -33.090,338 | -124.695,839 |
▸ Freie Cashflow Marge | -35,3% | -42,47% | -30,03% | -62,81% | -8,17% | 5,31% | -61,97% | -39,69% | -27,19% | -388,88% | -1.420,67% |
Ausgeschüttete Dividenden | -239.601,205 | -118.751,746 | -57.614,716 | -31.977,57 | -6.043,22 | -11.631,663 | -4.470 | -8.384,41 | -59.113,111 | - | -4.424,357 |
Neuausgabe und Rückkäufe von Stammaktien | - | - | - | - | -762.629,38 | - | - | - | - | - | - |
Kennzahlen dieser Seite im Lexikon
Weitere Informationen findest du im Takani-Lexikon.